Skip to main content
. 2012 Apr 18;2012(4):CD006243. doi: 10.1002/14651858.CD006243.pub2

6. Assessment of consistency of the treatment effect with respect to lymph nodal status.

  Lymph nodal status  
  Negative
HR (95% CI)
Positive
HR (95% CI)
RHR (95% CI)
BCIRG006 0.32 (0.17 to 0.62) 0.68 (0.52 to 0.86) 0.47 (0.23 to 0.94)
B31+N9831 0.47 (0.04 to 5.22) 0.48 (0.39 to 0.59)* 0.98 (0.09 to 11.23)
HERA 0.59 (0.39 to 0.91) 0.63 (0.51 to 0.78)* 0.94 (0.58 to 1.52)
NOAH 0.35 (0.09 to 1.29) 0.62 (0.39 to 0.98) 0.57 (0.14 to 2.32)
Summary 0.74 (0.51 to 1.08)

Q = 2.74 (dof = 3); P = 0.434; I2 = 0

* The hazard ratios (HRs) were obtained by pooling the HRs reported by the authors at different cut‐points
CI: confidence interval
RHR: ratios of HR